Literature DB >> 196049

Value of exchangeable electrolyte measurement in the treatment of myasthenia gravis.

M Critchley, K J Herman, M Harrison, R A Shields, L A Liversedge.   

Abstract

We have investigated electrolyte exchange in myasthenia gravis before and after corticotrophin therapy, using a four-isotope dilution technique. Clinical deterioration in patients on corticotrophin is associated with a fall of more than 20% in the intracellular potassium concentration, suggesting that all myasthenics so treated should be given potassium supplementation.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 196049      PMCID： PMC492658          DOI： 10.1136/jnnp.40.3.250

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  2 in total

1.  An electrophysiologic study of the neuromuscular junction in myasthenia gravis.

Authors:  O DAHLBACK; D ELMQVIST; T R JOHNS; S RADNER; S THESLEFF
Journal:  J Physiol       Date:  1961-04       Impact factor: 5.182

2.  Benefit from adrenocorticotrophin in myasthenia gravis.

Authors:  L A Liversedge; G M Yuill; I M Wilkinson; J A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154
  2 in total
  2 in total

1.  Genome-Wide Analysis of c-MYC-Regulated mRNAs and miRNAs and c-MYC DNA-Binding by Next-Generation Sequencing.

Authors:  Rene Jackstadt; Markus Kaller; Antje Menssen; Heiko Hermeking
Journal:  Methods Mol Biol       Date:  2021

2.  Intracellular electrolyte depletion in patients with ileostomies.

Authors:  L A Turnberg; A I Morris; P C Hawker; K J Herman; R A Shields; C E Horth
Journal:  Gut       Date:  1978-06       Impact factor: 23.059
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.